Skip to content

Clinical trials

Phase 1/2 Thyroid Neoplasms trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Thyroid Neoplasms Phase: Phase 1/2 Country / region: United States Clear all

20 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20041
20061
20091
20151
20161
20175
20192
20201
20211
20233
20241
20251
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed8
Terminated5
Active, not recruiting3
Recruiting3
Not yet recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Dana-Farber Cancer Institute2
Eli Lilly and Company2
Turning Point Therapeutics, Inc.2
Alume Biosciences, Inc.1
Arvinas Inc.1
Genmab1
Hoffmann-La Roche1
Institut de Recherches Internationales Servier1
Kineta Inc.1
M.D. Anderson Cancer Center1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Thyroid Neoplasms20
Carcinoma, Non-Small-Cell Lung12
Colonic Neoplasms10
Lung Neoplasms9
Head and Neck Neoplasms8
Neoplasms8
Breast Neoplasms7
Ovarian Neoplasms7
Carcinoma, Medullary6
Pancreatic Neoplasms6

Trials

Showing 1 to 20 of 20. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.